Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE)

20258 citationsJournal Articlehybrid Open Access

Authors

Koonlawee Nademanee · Chulalongkorn University

Wanwarang Wongcharoen · Chiang Mai University

Nitinan Chimparlee · Chulalongkorn University

Ronpichai Chokesuwattanaskul · Chulalongkorn University

Montawatt Annueypol · Mahidol University

Keerapa Phusunti · Maharat Nakhon Ratchasima Hospital

Dujdao Sahasatas

Abstract

Epicardial substrate ablation significantly reduces VF recurrence in patients with symptomatic BrS with implantable cardioverter-defibrillators and seems safe, supporting its potential role as a first-line therapy to prevent recurrent VF in patients with symptomatic BrS.

Topics & Keywords

Cardiac electrophysiology and arrhythmias Cardiac pacing and defibrillation studies ECG Monitoring and Analysis

Publication Details

Published in: Heart Rhythm

Volume 22, Issue 8, pp. 1975-1983

DOI: 10.1016/j.hrthm.2025.04.033

Field-Weighted Citation Impact: 11.68

Command Palette

Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE)

Authors

Abstract

Topics & Keywords

Publication Details